Business

Biopeak Secures Repeat Investment from Nikhil Kamath to Enhance Longevity Care in India

Biopeak, India's first longevity and health optimization brand, has successfully raised ₹2.7 million in funding from investor Nikhil Kamath. This investment aims to bolster Biopeak's multidisciplinary clinics and AI-driven diagnostics, including a new flagship center in Bengaluru. The company focuses on improving healthspan through preventative care tailored to Indian health profiles. With a growing demand for structured care, this funding will enhance Biopeak's capabilities across various health initiatives, including research and clinical program development.

MBN Business Reporter

MBN Business Reporter

May 11, 2026

15 views

Key Takeaways

  • Biopeak raises ₹2.7 million from Nikhil Kamath
  • Funding to enhance clinics and diagnostics
  • Focus on preventive care and healthspan now

Biopeak, India's pioneering longevity and health optimization brand, has successfully secured a significant funding of ₹2.7 million from prominent investor Nikhil Kamath. This repeat investment underscores the growing confidence in Biopeak's innovative approach to preventive healthcare and longevity in India. The funds will primarily be directed toward expanding multidisciplinary specialist-led clinics and enhancing diagnostic capabilities, alongside the establishment of a flagship center in Bengaluru.

Over the past year, Biopeak has made remarkable strides in addressing the gaps in India's healthcare system, particularly in the domain of preventive care. While the country has excelled in acute and episodic care, structured clinical models focusing on early detection and healthspan optimization remain scarce. Biopeak's strategy revolves around creating comprehensive specialist-led programs that integrate diagnostics, AI-driven insights, and sustained follow-up, tailored specifically to Indian health profiles and disease patterns.

  • Expansion of clinical programs — The funding will facilitate the growth of Biopeak's clinical initiatives, ensuring better health outcomes for clients.
  • New flagship center in Bengaluru — This center will serve as a hub for advanced diagnostics and specialist care.
  • Strengthening global partnerships — Biopeak aims to enhance its protocol development and governance through collaborations with international advisors.

In a statement addressing the recent funding, Rishi Pardal, Co-Founder and CEO of Biopeak, expressed optimism about the evolving perception of health in India. He stated, "There is a significant shift in how people view health, focusing on long-term wellness rather than just reactive care." This sentiment resonates with the company's mission to build a robust clinical system that integrates diagnostics, specialist care, and continuous health monitoring.

Founded by Rishi Pardal and Shiva Subramanian, Biopeak is committed to delivering science-backed longevity programs, particularly for high achievers and professionals. By leveraging advanced diagnostics and a multidisciplinary team of specialists, Biopeak aims to help individuals enhance their performance, resilience, and overall well-being. As the demand for preventive care continues to rise, Biopeak stands at the forefront of a healthcare revolution aimed at longevity and health optimization in India.

Wire Service: PTI
#Biopeak#Nikhil Kamath#longevity care#Bengaluru#health optimization#diagnostics#Rishi Pardal#AI-driven healthcare#preventive care#India

Related Articles